Minerva price target lowered to $7 from $11 at H.C. Wainwright
PremiumThe FlyMinerva price target lowered to $7 from $11 at H.C. Wainwright
5M ago
Minerva Neurosciences Reports First Quarter 2024 Financial Results and Business Updates
Premium
Press Releases
Minerva Neurosciences Reports First Quarter 2024 Financial Results and Business Updates
5M ago
Minerva reports Q1 EPS ($1.13) vs ($1.31) last year
Premium
The Fly
Minerva reports Q1 EPS ($1.13) vs ($1.31) last year
5M ago
Minerva receives complete response letter from FDA for NDA for roluperidone
PremiumThe FlyMinerva receives complete response letter from FDA for NDA for roluperidone
7M ago
Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Business Updates
Premium
Press Releases
Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Business Updates
7M ago
Minerva reports Q4 EPS ($1.19) vs. ($1.26) last year
Premium
The Fly
Minerva reports Q4 EPS ($1.19) vs. ($1.26) last year
7M ago
Minerva reports Q2 EPS ($1.12) vs. ($1.63) last year
PremiumThe FlyMinerva reports Q2 EPS ($1.12) vs. ($1.63) last year
1y ago
Minerva Neurosciences Reports 2023 Second Quarter Financial Results and Business Updates
Premium
Press Releases
Minerva Neurosciences Reports 2023 Second Quarter Financial Results and Business Updates
1y ago
Minerva prices 1.425M shares at $10.00 in private placement
Premium
The Fly
Minerva prices 1.425M shares at $10.00 in private placement
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100